NEOGENOMICS INC — Director's Dealing 2019

Mar 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-02-28

Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-28	Common Stock	M	20000	$7.52	Acquired	40000	Direct
2019-02-28	Common Stock	M	10000	$8.03	Acquired	50000	Direct
2019-02-28	Common Stock	S	30000	$19.57	Disposed	20000	Direct
2019-03-01	Common Stock	A	2862	—	Acquired	22862	Direct
2019-03-04	Common Stock	M	14000	$8.03	Acquired	36862	Direct
2019-03-04	Common Stock	S	14000	$19.09	Disposed	22862	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-28	Stock Option (Right to Buy)	$8.03	M	10000	Disposed	2023-02-26	Common Stock (10000.0)	Direct
2019-02-28	Stock Option (Right to Buy)	$7.52	M	20000	Disposed	2022-04-28	Common Stock (20000.0)	Direct
2019-03-01	Stock Option (Right to Buy)	$19.6	A	17496	Acquired	2024-03-01	Common Stock (17496.0)	Direct
2019-03-04	Stock Option (Right to Buy)	$8.03	M	14000	Disposed	2023-02-26	Common Stock (14000.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (16667.0)	16667	Direct

Footnotes

F1: Average price of shares sold.

F2: On February 26, 2018, Ms. Balliet was granted 72,500 stock options which vested ratably over the first three anniversary dates of the grant date.

F3: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date.

F4: On March 1, 2019, Ms. Balliet was granted 17,496 stock options which vested ratably over the first four anniversary dates of the grant date.

F5: On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vested ratably over the first three anniversary dates of the grant date.

F6: On April 20, 2016, Ms. Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.